{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-24-016265","form_type":"8-K","ticker":"ADGM","cik":"0002006986","company_name":"Adagio Medical Holdings, Inc.","filed_at":"2024-12-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.556714+00:00","generated_at":"2026-05-29T03:08:58.625037+00:00","sec_items":["1.01","5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Adagio Medical appoints Todd Usen as CEO; founder Olav Bergheim departs as CEO and Chairman","bullets":["Olav Bergheim resigns as CEO and Chairman effective Dec 13, 2024; receives severance of $1.2M cash plus contingent $300K.","Bergheim will serve as advisor for 12 months and receives an option for 338,398 shares of common stock.","Todd Usen appointed CEO and Director effective Dec 13, 2024; base salary $500K/year, bonus up to 50%, and option for ~5% fully diluted shares.","Orly Mishan appointed Chairperson of the Board effective Dec 13, 2024.","Bergheim's departure not due to disagreement with financial reporting or operations."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-24-016265","json":"https://secwatch.observer/filing/0001558370-24-016265.json","markdown":"https://secwatch.observer/filing/0001558370-24-016265.md","text":"https://secwatch.observer/filing/0001558370-24-016265.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2006986/000155837024016265/0001558370-24-016265-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2006986/000155837024016265/adgm-20241211x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T03:08:58.625037+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}